Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 6Phase 1 5Phase 1/2 3Phase EARLY_PHASE1 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

INDUSTRY 3OTHER 1NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 5Dermatologic 1

Conditions

Prostatic Neoplasms 25Lymphoma, Large B-Cell, Diffuse 23Burkitt Lymphoma 16Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Non-Hodgkin 9Lymphoma, Follicular 9Neoplasm Metastasis 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 6Lymphoma, B-Cell 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Lymphoma, T-Cell, Peripheral 5Leukemia 5Recurrence 4Neoplasms 4Lymphoma, T-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Biphenotypic, Acute 3Carcinoma, Non-Small-Cell Lung 3Thrombocythemia, Essential 2Primary Myelofibrosis 2

Interventions

Cyclophosphamide 8Vincristine 6romidepsin 5Prednisone 5Doxorubicin 5Lenalidomide 4Etoposide 4fludarabine phosphate 3fludarabine 3Rituximab 3Dexamethasone 3Bortezomib 3Azacitidine 3selinexor 2darinaparsin 2carfilzomib 2belinostat 2Oxaliplatin 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Ipilimumab 2Injections 2Gemcitabine 2Depsipeptides 2Dasatinib 2Carboplatin 2CTLA-4 Antigen 2Brentuximab Vedotin 2Biopsy 2Bendamustine Hydrochloride 2Alemtuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Lymphoma, T-Cell, Peripheral × Prednisone × Clear all
NCT04548700 2024-03-07

Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Terminated
38 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT05458180 2022-07-14

CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma

Tianjin Medical University Cancer Institute and Hospital

Phase 1 Unknown
18 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT01445535 2021-11-03

Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
15 enrolled 18 charts
DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Lymphoma, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

NCT01839097 2020-01-03

Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)

Acrotech Biopharma Inc.

Phase 1 Completed
23 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT02809573 2019-07-24

Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients

Chipscreen Biosciences, Ltd.

Phase 1 Completed
30 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡